"All-in monthly pricing" — then it says the drug is billed separately.
Its weight-loss page runs that heading directly above the sentence "Medication, labs, and treatment supplies are billed separately by our independent clinical partner." Its financial policy removes the consultation from the price too.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
The catch — Three surfaces, three different scopes for one number. The weight-loss page is headed "All-in monthly pricing." and immediately adds "Medication, labs, and treatment supplies are billed separately by our independent clinical partner", while the plan cards beneath it list the compounded medication and the syringes as what you get. The pricing page says the monthly figure covers consultation, protocol design, dose adjustments and follow-up, with medication billed separately. The financial policy says NEUVÉ only charges for membership and coaching, and that medication, labs, clinician consultations and supplies are all billed by someone else — which removes the consult as well.
Prices read from NEUVÉ Health's own site · September 2026
What they advertise
$179/month for an injectable semaglutide microdose with B12 and $240 for tirzepatide, with daily sublingual versions at $138 and $160, published openly on its pricing page alongside dozens of other protocols and lab panels.
What you actually pay
Not established, and the obstacle is scope rather than access. The figures above are published and unambiguous as numbers; what they contain is not. Its weight-loss page lists the compounded medication and injection supplies as what the price buys, and on the same page says medication and supplies are billed separately. Until NEUVÉ says which, the monthly cost of treatment here cannot be stated.
Money you will meet later
Lab panels through Quest or LabCorp, at prices its pricing page publishes separately.
Its three membership tiers are named and none of them is priced anywhere on the site.
The bottom line
NEUVÉ Health — Neuve Health, LLC, of Gilbert, Arizona — publishes one of the fullest price ladders on this site: dozens of protocols, doses and lab panels, all rendering without an account. Compounded semaglutide runs $179 a month as an injectable microdose with B12 and $138 as a daily sublingual; tirzepatide is $240 and $160. The reason none of that is ranked is that NEUVÉ cannot say what the figure buys. One page calls it all-in, then says medication is billed separately. Another says the same. Its financial policy goes further and puts the clinician consultation outside the price too.
NEUVÉ Health is not ranked on any of our boards. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our tirzepatide provider ranking. Nothing on this page is a performance claim.
You want to see the whole menu before anything is asked of you — its pricing page renders every protocol, dose and lab price with no account.
You want a daily sublingual option priced separately from the injection rather than bundled at one rate.
You want the labs named: it uses Quest and LabCorp, and says panel pricing is confirmed before you are charged.
Look elsewhere if
You need to know whether the price includes the drug. Three of its own pages answer that differently, and the one headed "All-in monthly pricing" is the one that says it does not.
You want a physician named. The only person named on the site is its founder, who is described as a nurse practitioner and a wellness director, not as a doctor.
You are comparing it against all-in monthly rates elsewhere — until the scope is settled, the numbers are not comparable.
Who fills your prescription
No category stated
NEUVÉ Health does not name the pharmacy that fills your prescription.
What its own site says ↓↑
No pharmacy is named, though the class is stated more carefully than most providers here manage: "COMPOUNDED BY U.S. 503A pharmacy" on the homepage and 503A/503B certified pharmacies on the About page. No facility, no license number, no NPI. Its labs are named — Quest and LabCorp. One person is named on the entire site, its founder, and he is presented as a nurse practitioner and regional wellness director rather than a physician; no MD appears anywhere.
What's the difference between 503A and 503B? ↓↑
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
Where you can get it
Not stated
Its FAQ claims all 50 states and its quiz's own state map offers 50 plus the District of Columbia, while the same homepage prints "Members in 40+ states" twice. Its About page draws the distinction the homepage does not — 50 states reviewed against 40-plus states with members — so the two claims are reconcilable, just not where most readers meet them.
The honest cons
The part they would rather you skipped
NEUVÉ heads a page "All-in monthly pricing." and then, in the next sentence on that same page, says "Medication, labs, and treatment supplies are billed separately by our independent clinical partner." Directly beneath both, its plan cards list the compounded semaglutide and the injection supplies as what the price includes. That is two answers on one screen. Its pricing page gives a third scope — consultation, protocol design and follow-up, with medication separate — and its financial policy gives a fourth, stating that NEUVÉ charges only for membership and coaching and that medication, labs, clinician consultations and supplies are all billed by someone else. So the published figure might be a full treatment cost or it might be a coaching fee with the drug still to come, and nothing on the site settles it. Alongside that, three membership tiers are named and none of them carries a price, and a credential claim repeated four times — that its network is curated from clinicians trained at named elite medical schools — is attached to no clinician a reader can check, because no physician is named anywhere on the site.
Its own pages give three different answers to whether the monthly price includes the medication — see this review's knock.
Three membership tiers are named and none is priced.
No physician is named anywhere; the only named individual is a nurse practitioner and wellness director.
A training-pedigree claim is repeated four times and attached to no checkable clinician.
Its homepage runs "all 50 states" and "members in 40+ states" side by side without the distinction its About page draws.
Lab panels are required and priced separately from the monthly figure.
Membership fees are non-refundable once a billing period has begun.
None of this is unique to NEUVÉ Health — the whole category shares it.
The providers we rank on our tirzepatide provider ranking, in the order that board ranks them. NEUVÉ Health is not among them: it is reviewed here, not ranked there, and we would rather show you the comparison than pretend the two are the same thing.
A provider comparison is half the decision. The other half is whether the compound does anything for you at all. The evidence below is where that gets settled.
Prices and plans in this category change often — check NEUVÉ Health's current pricing before you decide. Ours was read from their own site in September 2026.
Facts on this page reflect NEUVÉ Health's own public disclosures when we last checked them, in September 2026. Prices and terms change without notice — confirm on NEUVÉ Health's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved. See our disclosure and editorial policy.